197 related articles for article (PubMed ID: 26663076)
21. Role of the extended alpha4 domain of Staphylococcus aureus gyrase A protein in determining low sensitivity to quinolones.
Strahilevitz J; Robicsek A; Hooper DC
Antimicrob Agents Chemother; 2006 Feb; 50(2):600-6. PubMed ID: 16436716
[TBL] [Abstract][Full Text] [Related]
22. Interaction of nalidixic acid and ciprofloxacin with wild type and mutated quinolone-resistance-determining region of DNA gyrase A.
Vashist J; Vishvanath ; Kapoor R; Kapil A; Yennamalli R; Subbarao N; Rajeswari MR
Indian J Biochem Biophys; 2009 Apr; 46(2):147-53. PubMed ID: 19517991
[TBL] [Abstract][Full Text] [Related]
23. Characterization of Salmonella Typhimurium DNA gyrase as a target of quinolones.
Kongsoi S; Yokoyama K; Suprasert A; Utrarachkij F; Nakajima C; Suthienkul O; Suzuki Y
Drug Test Anal; 2015 Aug; 7(8):714-20. PubMed ID: 25381884
[TBL] [Abstract][Full Text] [Related]
24. Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone.
Ince D; Zhang X; Silver LC; Hooper DC
Antimicrob Agents Chemother; 2002 Nov; 46(11):3370-80. PubMed ID: 12384338
[TBL] [Abstract][Full Text] [Related]
25. DNA gyrase from the albicidin producer Xanthomonas albilineans has multiple-antibiotic-resistance and unusual enzymatic properties.
Hashimi SM; Huang G; Maxwell A; Birch RG
Antimicrob Agents Chemother; 2008 Apr; 52(4):1382-90. PubMed ID: 18268084
[TBL] [Abstract][Full Text] [Related]
26. Quinolone resistance-associated amino acid substitutions affect enzymatic activity of Mycobacterium leprae DNA gyrase.
Yamaguchi T; Yokoyama K; Nakajima C; Suzuki Y
Biosci Biotechnol Biochem; 2017 Jul; 81(7):1343-1347. PubMed ID: 28417702
[TBL] [Abstract][Full Text] [Related]
27. QnrS1 structure-activity relationships.
Tavío MM; Jacoby GA; Hooper DC
J Antimicrob Chemother; 2014 Aug; 69(8):2102-9. PubMed ID: 24729602
[TBL] [Abstract][Full Text] [Related]
28. Quinolone-binding pocket of DNA gyrase: role of GyrB.
Heddle J; Maxwell A
Antimicrob Agents Chemother; 2002 Jun; 46(6):1805-15. PubMed ID: 12019094
[TBL] [Abstract][Full Text] [Related]
29. A Putative Chloroplast Thylakoid Metalloprotease VIRESCENT3 Regulates Chloroplast Development in Arabidopsis thaliana.
Qi Y; Liu X; Liang S; Wang R; Li Y; Zhao J; Shao J; An L; Yu F
J Biol Chem; 2016 Feb; 291(7):3319-32. PubMed ID: 26702056
[TBL] [Abstract][Full Text] [Related]
30. Targeting novel sites in DNA gyrase for development of anti-microbials.
Salman M; Sharma P; Kumar M; Ethayathulla AS; Kaur P
Brief Funct Genomics; 2023 Apr; 22(2):180-194. PubMed ID: 36064602
[TBL] [Abstract][Full Text] [Related]
31. Engineering the specificity of antibacterial fluoroquinolones: benzenesulfonamide modifications at C-7 of ciprofloxacin change its primary target in Streptococcus pneumoniae from topoisomerase IV to gyrase.
Alovero FL; Pan XS; Morris JE; Manzo RH; Fisher LM
Antimicrob Agents Chemother; 2000 Feb; 44(2):320-5. PubMed ID: 10639357
[TBL] [Abstract][Full Text] [Related]
32. crinkled leaves 8--a mutation in the large subunit of ribonucleotide reductase--leads to defects in leaf development and chloroplast division in Arabidopsis thaliana.
Garton S; Knight H; Warren GJ; Knight MR; Thorlby GJ
Plant J; 2007 Apr; 50(1):118-27. PubMed ID: 17346262
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of binding of fluoroquinolones to the quinolone resistance-determining region of DNA gyrase: towards an understanding of the molecular basis of quinolone resistance.
Madurga S; Sánchez-Céspedes J; Belda I; Vila J; Giralt E
Chembiochem; 2008 Sep; 9(13):2081-6. PubMed ID: 18677735
[TBL] [Abstract][Full Text] [Related]
34. Structural insights into quinolone antibiotic resistance mediated by pentapeptide repeat proteins: conserved surface loops direct the activity of a Qnr protein from a gram-negative bacterium.
Xiong X; Bromley EH; Oelschlaeger P; Woolfson DN; Spencer J
Nucleic Acids Res; 2011 May; 39(9):3917-27. PubMed ID: 21227918
[TBL] [Abstract][Full Text] [Related]
35. Dual Escherichia coli DNA Gyrase A and B Inhibitors with Antibacterial Activity.
Fois B; Skok Ž; Tomašič T; Ilaš J; Zidar N; Zega A; Peterlin Mašič L; Szili P; Draskovits G; Nyerges Á; Pál C; Kikelj D
ChemMedChem; 2020 Feb; 15(3):265-269. PubMed ID: 31721445
[TBL] [Abstract][Full Text] [Related]
36. Impact of the E540V amino acid substitution in GyrB of Mycobacterium tuberculosis on quinolone resistance.
Kim H; Nakajima C; Yokoyama K; Rahim Z; Kim YU; Oguri H; Suzuki Y
Antimicrob Agents Chemother; 2011 Aug; 55(8):3661-7. PubMed ID: 21646485
[TBL] [Abstract][Full Text] [Related]
37. Interaction of the plasmid-encoded quinolone resistance protein QnrB19 with Salmonella Typhimurium DNA gyrase.
Pachanon R; Koide K; Kongsoi S; Nakajima C; Kapalamula TF; Suthienkul O; Suzuki Y
J Infect Chemother; 2020 Nov; 26(11):1139-1145. PubMed ID: 32669211
[TBL] [Abstract][Full Text] [Related]
38. CRISPR/Cas9/sgRNA-mediated targeted gene modification confirms the cause-effect relationship between gyrA mutation and quinolone resistance in Escherichia coli.
Qiu H; Gong J; Butaye P; Lu G; Huang K; Zhu G; Zhang J; Hathcock T; Cheng D; Wang C
FEMS Microbiol Lett; 2018 Jul; 365(13):. PubMed ID: 29767711
[TBL] [Abstract][Full Text] [Related]
39. Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins.
Pan XS; Yague G; Fisher LM
Antimicrob Agents Chemother; 2001 Nov; 45(11):3140-7. PubMed ID: 11600369
[TBL] [Abstract][Full Text] [Related]
40. Structure based in silico analysis of quinolone resistance in clinical isolates of Salmonella Typhi from India.
Kumar M; Dahiya S; Sharma P; Sharma S; Singh TP; Kapil A; Kaur P
PLoS One; 2015; 10(5):e0126560. PubMed ID: 25962113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
